Stocks股票 / Health Care / COR
COR US listed · USD美股 · 美元
Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale and distribution company and a contract research organization, that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. It was renamed to Cencora in 2023.Cencora公司,前身为AmerisourceBergen,是一家美国药品批发和分销公司及合同研究机构,由Bergen Brunswig和AmeriSource于2001年合并而成,2023年更名为Cencora。
The latest call, in context把最新财报放回历史脉络
A synthesized event record across management commentary and recorded metrics. Read as context; verify exact wording in the transcript before relying.综合管理层表述与记录指标形成事件档案。仅供参考;使用前请在电话会原文中核对准确措辞。
Live company record实时公司记录
JavaScript loads the source-bounded event record here. Open Terminal if the live module does not start.JavaScript 会在此加载受来源约束的事件记录。如实时模块未启动,请打开终端。
Continue with full transcript history继续查看完整电话会历史 ↗Price chart价格图表
Technicals技术面
daily bars日线数据 · 2026-09-28Earnings财务业绩
next report下次财报 2026-11-04Estimates being cut预期下调
Beat in 3 of last 4 quarters近 4 季中 3 季超预期
EPS surprise vs consensus, last quarters每股收益相对预期的超预期幅度(近几个季度) · average平均 0.8%
Valuation估值
Roughly fair vs sector相对行业估值合理| Multiple指标 | COR | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率(历史) | 38.41x | 29.58 | |
| P/B市净率 | 31.29x | 3.30 | |
| P/S市销率 | 0.19x | 3.19 | |
| Earnings yield盈利收益率 | 2.60% | 2.56 | |
| FCF yield自由现金流收益率 | 5.37% | 4.11 | |
| Shareholder yield股东收益率 | 1.46% | 1.87 | |
| EV/EBITDA企业价值/EBITDA | 17.12x | 18.26 | |
| P/FCF市值/自由现金流 | 18.62x | 21.34 |
Financials财务数据
fiscal years财年Leverage杠杆
Capital allocation资本配置
Debt coming due到期债务
FY2025 10-KIn the 12-month bucket following fiscal period end 2025-09-30, it reported $115.2M due — about 2% of its disclosed principal.在财年期末 2025-09-30 之后12个月的区间内,已披露到期本金为 $115.2M,约占其披露本金的 2%。
All maturity buckets are measured from fiscal period end 2025-09-30, not from today.所有到期区间均从财年期末 2025-09-30 起算,而非从今天起算。
Cash reported at 2025-09-30: $4356138000.截至 2025-09-30 披露的现金:$4356138000。 Operating cash flow exceeded or equaled equipment spending over 2024-10-01 to 2025-09-30; no cash burn to measure.在 2024-10-01 至 2025-09-30 期间,经营现金流不低于设备支出,无可衡量的现金消耗。
Cash reported at 2025-09-30 covers 3781% of issuer-reported principal in the 12-month bucket following that fiscal period end.截至 2025-09-30 披露的现金可覆盖该财年期末之后12个月区间内发行人已披露到期本金的 3781%。
Cash shortfall against that reported principal: $0相对该已披露本金的现金缺口:$0。
Sources and cash-flow calculation来源与现金流计算
Figures are XBRL facts from one filing — no two years are mixed. Filing数据取自同一份文件中的 XBRL 事实,不跨文件拼接。文件
0001140859-25-000131, period ending报告期截至 2025-09-30, unit单位 USD.
Cache acquired缓存获取时间: 2026-09-23T08:00:39.967694+00:00.
6/6 buckets reported.个区间有披露。
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonthsLongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwoLongTermDebtMaturitiesRepaymentsOfPrincipalInYearThreeLongTermDebtMaturitiesRepaymentsOfPrincipalInYearFourLongTermDebtMaturitiesRepaymentsOfPrincipalInYearFiveLongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
Annual period年度区间 2024-10-01 — 2025-09-30 · USD · 10-K · 0001140859-25-000131 · Filed提交日期 2025-11-25.
Cache acquired缓存获取时间: 2026-09-23T08:00:39.967694+00:00 · Evaluated as of评估截至 2026-09-28.
- Reported operating cash flow已披露经营活动现金流: $3875120000
- Reported equipment spending (capex outflow)已披露设备支出(资本开支流出): $667981000
- Derived free cash flow (operating cash flow minus capex)计算所得自由现金流(经营现金流减资本开支): $3207139000
Cash is the reported balance at period end. The runway scenario holds this annual cash-flow pace constant and excludes debt payments, restricted-cash adjustments and future financing.现金为期末已披露余额。现金跑道情景假设本年度现金流速度保持不变,不包括债务偿还、受限现金调整与未来融资。
Why is it moving为何波动
6 checks · nightly六项检查 · 每晚Options positioning期权持仓
as of last close截至上一收盘Market makers are net long gamma — price pinned near current level做市商净持有正伽玛,价格倾向于在当前水平附近震荡
Ownership & smart money持仓与聪明钱
13FInsider activity:内部人动向: -$1.3M net (2 buyers, 1 sellers)-$1.3M 净值(2 买家,1 卖家)
Signal history信号历史
engine events引擎事件Company profile公司档案
Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale and distribution company and a contract research organization, that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. It was renamed to Cencora in 2023.Cencora公司,前身为AmerisourceBergen,是一家美国药品批发和分销公司及合同研究机构,由Bergen Brunswig和AmeriSource于2001年合并而成,2023年更名为Cencora。
- Capital intensity rising
The whole US universe — S&P 1500 and Russell 2000 — read nightly.覆盖标普1500与罗素2000全部成分股 — 每晚更新解读。
Signals, options positioning, smart-money moves and factor DNA — the same engine that wrote this page covers 2,700+ US stocks.信号、期权持仓、聪明钱动向与因子基因 — 撰写本页的引擎覆盖2700多只美股。
Valuation vs sector估值对比行业
| Multiple指标 | This stock本股 | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率(静态) | 38.4× | 29.6× | 36% |
| Price / Book市净率 | 31.3× | 3.3× | 3% |
| Price / Sales市销率 | 0.2× | 3.2× | 99% |
| EV / EBITDAEV/EBITDA | 17.1× | 18.3× | 55% |
| Earnings yield盈利收益率 | 2.6% | 2.6% | 53% |
| Free-cash-flow yield自由现金流收益率 | 6.5% | 5.5% | 66% |
| Shareholder yield股东综合回报率 | 1.5% | 1.9% | 41% |
Relative strength相对强度
Price history价格历史
| Period周期 | This stock本股 | S&P 500标普500 |
|---|---|---|
| 1 Week近1周 | -0.6% | +1.3% |
| 1 Month近1月 | -6.4% | +0.9% |
| 3 Months近3月 | +7.3% | +6.1% |
| 6 Months近6月 | -1.5% | +22.3% |
| Year to date年初至今 | -9.1% | +13.8% |
| 1 Year近1年 | +3.3% | +18.5% |
Trading information交易信息
Multi-year record多年财务记录
| 20202020 | 20212021 | 20222022 | 20232023 | 20242024 | 20252025 | |
|---|---|---|---|---|---|---|
| Revenue营业收入 | $189.9B | $214.0B | $238.6B | $262.2B | $294.0B | $321.3B |
| EPS每股收益 | $-16.65 | $7.39 | $8.04 | $8.53 | $7.53 | $7.96 |
| Free cash flow自由现金流 | $1.8B | $2.2B | $2.2B | $3.5B | $3.0B | $3.2B |
| Gross margin毛利率 | 2.7% | 3.2% | 3.5% | 3.4% | 3.4% | 3.6% |
| Net margin净利率 | -1.8% | 0.7% | 0.7% | 0.7% | 0.5% | 0.5% |
| FCF margin自由现金流利润率 | 1.0% | 1.0% | 0.9% | 1.3% | 1.0% | 1.0% |
Latest fiscal year最近财年
Returns & growth回报与增长
Accounting quality checks会计质量检查
- Earnings quality: accruals trending up over 6 fiscal years — earnings increasingly not cash-backed盈利质量:应计利润在 6 个财年间走高——盈利的现金支撑减弱
- Working capital: working capital roughly in line with sales营运资本:营运资本与销售大致同步
- Pricing power: soft gross profitability vs peers定价能力:毛利能力弱于同业
- Capital discipline: investment near the peer median资本纪律:投资力度接近同业中位
- Balance sheet: Altman Z 4.82 — safe zone资产负债表:Altman Z 4.82——安全区
Indicator readings指标读数
Timeframe alignment多周期共振
Volatility regime波动状态
Surprise history超预期历史
| Quarter季度 | Reported实际 | Expected预期 | Surprise超预期 |
|---|---|---|---|
| Jun 2026 | $4.48 | $4.37 | +2.5% |
| Mar 2026 | $4.75 | $4.80 | -1.0% |
| Dec 2025 | $4.08 | $4.07 | +0.2% |
| Sep 2025 | $3.84 | $3.79 | +1.3% |